Physician

Fayez Chahfe, MD

According to 2025 Medicare claims, Fayez Chahfe, MD (NPI: 1164411567) practices otolaryngology in the Utica-Rome, NY market, with the plurality of this provider's patient population coming from Oneida, NY. Chahfe uses personal NPI as billing NPI and primary practice location at 13502-5836. Chahfe is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), Trinity Health Integrated Care (ACO ID: A3454), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Chahfe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 859 traditional Medicare patients, billed 2,170 HCPCS/CPT codes, and received $279,530 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 3,445 prescription claims across 941 beneficiaries totaling $67,998 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). DME data shows 31 claims. Open Payments data shows 48 records totaling $1,466. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $47,345 to $67,998. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,346 to $4,017.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	931	2,497	$203,495
2016	928	2,808	$241,292
2017	895	2,545	$209,055
2018	930	2,618	$237,994
2019	917	2,550	$267,186
2020	800	2,315	$256,131
2021	885	2,470	$275,755
2022	976	2,455	$264,918
2023	987	2,549	$292,474
2024	859	2,170	$279,530

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	463	1,418	$47,345
2016	533	1,801	$59,046
2017	553	1,796	$51,444
2018	568	1,827	$51,167
2019	641	2,041	$48,025
2020	610	2,141	$47,978
2021	729	2,641	$60,684
2022	784	2,851	$107,162
2023	883	3,322	$117,702
2024	941	3,445	$67,998

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	214	$19,010
2016	N/R	306	$18,259
2017	N/R	40	$3,163
2018	N/R	38	$2,936
2019	N/R	64	$3,537
2020	N/R	93	$3,875
2021	N/R	38	$3,574
2022	N/R	20	$2,989
2023	N/R	22	$3,318
2024	N/R	31	$3,857

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	45	46	$141
31575	Diagnostic exam of voice box using a flexible endoscope	324	394	$94
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	259	259	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	628	1,041	$66
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	52	64	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	480	6,758	$12,738
Omeprazole	Omeprazole	327	18,726	$5,599
Azelastine Hcl	Azelastine Hcl	169	7,425	$5,331
Fluticasone Propionate	Fluticasone Propionate	287	11,079	$3,741
Cefdinir	Cefdinir	183	2,173	$3,337

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4624	Tracheal suction catheter, any type other than closed system, each	N	N/R	31	$3,857

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$1,466	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fayez Chahfe, MD?

Tedicare shows public-source Medicare data for Fayez Chahfe, MD (NPI 1164411567), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fayez Chahfe, MD have ACO affiliation data?

Fayez Chahfe, MD is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612), Trinity Health Integrated Care (MSSP, ACO ID A3454), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Fayez Chahfe, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Fayez Chahfe, MD have Open Payments data?

Fayez Chahfe, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.